Diabetes Care by Cheng, Yiling J. et al.
Secular Changes in the Age-Specific
Prevalence of Diabetes Among U.S.
Adults: 1988–2010
YILING J. CHENG, MD, PHD1
GIUSEPPINA IMPERATORE, MD, PHD1
LINDA S. GEISS, MA1
JING WANG, MD, MPH1
SHARON H. SAYDAH, PHD1
CATHERINE C. COWIE, PHD2
EDWARD W. GREGG, PHD1
OBJECTIVEdTo examine the age-specific changes of prevalence of diabetes among U.S.
adults during the past 2 decades.
RESEARCH DESIGN AND METHODSdThis study included 22,586 adults sampled
in three periods of the National Health and Nutrition Examination Survey (1988–1994,
1999–2004, and 2005–2010). Diabetes was defined as having self-reported diagnosed
diabetes or having a fasting plasma glucose level $126 mg/dL or HbA1c $6.5%
(48 mmol/mol).
RESULTSdThe number of adults with diabetes increased by 75% from 1988–1994 to
2005–2010. After adjusting for sex, race/ethnicity, and education level, the prevalence of
diabetes increased over the two decades across all age-groups. Younger adults (20–34 years
of age) had the lowest absolute increase in diabetes prevalence of 1.0%, followed by middle-
aged adults (35–64) at 2.7% and older adults ($65) at 10.0% (all P , 0.001). Comparing
2005–2010 with 1988–1994, the adjusted prevalence ratios (PRs) by age-group were 2.3, 1.3,
and 1.5 for younger, middle-aged, and older adults, respectively (all P , 0.05). After addi-
tional adjustment for body mass index (BMI), waist-to-height ratio (WHtR), or waist circum-
ference (WC), the adjusted PR remained statistically significant only for adults $65 years
of age.
CONCLUSIONSdDuring the past two decades, the prevalence of diabetes increased across
all age-groups, but adults$65 years of age experienced the largest increase in absolute change.
Obesity, as measured by BMI, WHtR, or WC, was strongly associated with the increase in di-
abetes prevalence, especially in adults ,65.
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D iabetes leads to microvascular com-plications and increased risk ofcardiovascular disease morbidity
and mortality. Unfortunately, the preva-
lence of diabetes in the U.S. has increased
over the past 2 decades (1), paralleled by
increasing obesity, aging, and a combi-
nation of changes in personal lifestyle,
environmental conditions, population
demographic characteristics, and im-
proved survival of persons with diabetes
(2,3). It is less clear whether the preva-
lence of diabetes (diagnosed and undiag-
nosed) has increased to the same degree
across all age-groups and what role
the presence of obesity plays in the prev-
alence of diabetes across age catego-
ries. Having a better understanding of
the diabetes burden and changes over
time across age categories of the U.S.
population is essential for the delivery
of primary and secondary prevention
interventions, planning of health serv-
ices, and allocation of limited health
care resources.
The U.S. National Health and Nutri-
tion Examination Survey (NHANES) is an
ongoing, national, multiple-phase, cross-
sectional survey that contains informa-
tion on self-reported diabetes status and
laboratory measurements of blood glu-
cose levels, thus allowing the examination
of trends in both diagnosed and undiag-
nosed diabetes. In this study, we exam-
ined changes in the age-specific total
diabetes prevalence among U.S. adults
and the association of these changes
with body mass index (BMI), waist-to-
height ratio (WHtR), and waist circum-




Population and data collection
NHANES is designed to represent the
U.S. noninstitutionalized civilian popula-
tion. The NHANES III was conducted
from 1988 to 1994. Beginning in 1999,
NHANES became a yearly survey, with
data released every 2 years. For this study,
we divided the continuous NHANES
administration into two segments of 6
years each (NHANES 1999–2004 and
NHANES 2005–2010). NHANES uses a
complex, multistage sample design. Par-
ticipants are selected for a home interview
and then invited to participate in a med-
ical examination in a mobile center. One-
half of sampled households in the survey
are randomly assigned to a morning fast-
ing blood collection. Detailed exclusion
criteria, phlebotomy collection and pro-
cessing, and body measurement instruc-
tions are discussed in the NHANES online
documents (4).
We included all adults with self-
reported diagnosed diabetes in the in-
terview sample and adults without
diagnosed diabetes selected for the morn-
ing medical examination session (n =
23,972). Among adults without diag-
nosed diabetes, we excluded those who
were pregnant (n = 637), without a fasting
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plasma glucose (FPG) level (n = 705), and
without a glycated hemoglobin A1c
(HbA1c) value (n = 44). The final analytic
sample included 22,586 adults (7,950 for
1988–1994, 6,756 for 1999–2004, and
7,880 for 2005–2010) among whom
1,441 had missing values on body weight
(n = 625), body height (n = 631), andWC
(n = 1,353).We used the full analytic sam-
ple for estimating crude or demographi-
cally adjusted prevalence, and the full
analytic sample with 10 sets of multiple
imputed BMI, WHtR, and WC values for
BMI-, WHtR-, and WC-related analyses.
Definition of diabetes
Adults were classified as having diag-
nosed diabetes if they answered yes to
the question, “Other than during preg-
nancy (for women aged $20 years),
have you ever been told by a doctor or
health professional that you have diabetes
or sugar diabetes?” FPG level was mea-
sured with the same hexokinase enzy-
matic method in both the NHANES III
and the continuous NHANES 1999–
2010. HbA1c was measured by high-
performance liquid chromatography, as
used in the Diabetes Control and Compli-
cations Trial (4). To make FPG levels com-
parable across surveys, we used crossover
regression equations recommended by
the National Center for Health Statistics
(5); we did not use crossover equations
for HbA1c across surveys (6). Adults with-
out diagnosed diabetes but with an FPG
level of $126 mg/dL (7.0 mmol/L) or
HbA1c $6.5% (48 mmol/mol) were
classified as having undiagnosed dia-
betes. Therefore, diabetes was defined
as having either diagnosed or undiag-
nosed diabetes.
Covariates
The anthropometric data were collected
by trained health technicians in accor-
dance with the NHANES Anthropometry
Procedures Manual (7). No changes to
these measurements have been made to
the NHANES since 1988. All survey par-
ticipants were eligible for the body mea-
surement component. Body weight (kg)
was measured on a floor scale. Height
(m) was measured with a wall-mounted
stadiometer. Standing WC was measured
just above the uppermost lateral border of
the ilium. BMI was equal to weight di-
vided by height squared. BMI (kg/m2)
was assigned to six categories for de-
scription of characteristics as follows:
underweight (,18.5), normal weight
(18.5–24.9), overweight (25.0–29.9),
obese I (30.0–34.9), obese II (35.0–
39.9), and obese III ($40).
Although BMI has been used to mon-
itor overall obesity trends (8), WHtR and
WC were used as surrogates of distribu-
tion of adipose tissues, especially abdom-
inal fat deposition (9). In multivariate
models, we used BMI, WHtR, and WC
separately.
We analyzed age in years as a contin-
uous and as a categorical variable (youn-
ger adults 20–34, middle-aged adults
35–64, and older adults $65) based on
the results of the Joinpoint model (10). The
study also included the following self-
reported demographic variables: sex,
race/ethnicity (non-Hispanic white,
non-Hispanic black, Mexican American,
other Hispanic, and other), and highest
education level attained (less than high
school, high school graduate, and more
than high school).
Statistical methods
To account for the differences in the
probability of selection and the design
of the survey and to provide nationally
representative estimates, all analyses
were weighted to the U.S. population
and analyzed with the survey module
of Stata 12.1 (StataCorp LP, College
Station, TX) according to NHANES an-
alytic guidelines (11). Initial sampling
weights were chosen on the basis of in-
terview sampling weights for adults with
diagnosed diabetes and morning FPG
sampling weights for adults without di-
agnosed diabetes. Poststratification pro-
cedures involved adjustment of sampling
weights so that they sum to the popula-
tion sizes within each stratum, thereby
reducing bias as a result of nonresponse
and underrepresented groups in the
population. Thus, after excluding the
adults without measurements of FPG or
HbA1c and pregnant women among sam-
pled adults without diagnosed diabetes,
we reweighted the sample of adults
without diagnosed diabetes to sum the
weights of individuals to the total in-
terview weight of all adults without
diagnosed diabetes according to the pro-
vided poststrata of the U.S. noninstitu-
tionalized population (12). There was
no reweighting for adults with diagnosed
diabetes; the sum of sample weights of
those with and without diabetes added
to the total noninstitutionalized U.S.
population for each survey period.
We used multiple imputation (MI)
technology with chained equations to im-
pute the missing values for BMI (n = 704),
WC (n = 1,353), and WHtR (n = 1,412).
The imputation model of missing values
included all dependent and independent
variables of logistic models plus sampling
design variables (primary sampling unit,
stratum). Ten sets of multiple imputed
data, which is much.100 times the larg-
est fraction of missing information
(0.0048 3 100), were generated to pro-
vide an adequate level of reproducibility of
the MI analysis. The MI module with the
survey prefix command of Stata was used
for MI data analysis.
We used the Joinpoint Regression
Program version 3.5.2 (National Cancer
Institute, Bethesda, MD) to find age-
specific inflection points (i.e., joinpoints,
breakpoints, or knots) in the prevalence
of diabetes by 5-year age-groups (10). On
the basis of the logarithm of diabetes
prevalence, Joinpoint regression analysis
detected two inflection points for age
(shown in parentheses) for eachNHANES
time period as follows: 1988–1994 (35
and 60), 1999–2004 (45 and 65), and
2005–2010 (35 and 65). Because the as-
sociation of age with diabetes prevalence
was not linear across the whole age range,
piecewise regression incorporating inflec-
tion points for change was appropriate for
fitting a model of age, as a continuous
variable, and diabetes prevalence.
From the inflection points of the
entire sample from 1988 to 2010, we
divided the combined survey sample of
1988–2010 into three adult age-groups in
years: younger (20–34), middle-aged
(35–64), and older ($65). We examined
absolute change (i.e., prevalence differ-
ence [PD]) and relative change (i.e., prev-
alence ratio [PR]) in diabetes prevalence
between two different survey periods for
these three age-groups. The prevalence,
PR, and 95% CIs were estimated by pre-
dicted margins from logistic regression
models. Sex, race/ethnicity, education
level, and year of survey were included
in analyses as categorical variables; age
and BMIwere treated as either continuous
or categorical in various analyses; and
WHtR and WC were used as continuous
variables. We tested the interaction terms
of age with BMI, WHtR, and WC (all P.
0.05) as well as without these terms in the
analyses. We calculated PD and PR for
comparison between extreme survey
time periods of diabetes. The Taylor series
linearizationmethodwas used to estimate
SEs as a default method; the delta method
was used to estimate SEs of combinations
of estimates, such as PR. An estimate
with a two-sided P , 0.05 or a 95% CI
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that did not include a null value was con-
sidered statistically significant.
RESULTSdAcross the three NHANES
time periods (1988–1994, 1999–2004,
and 2005–2010), mean age, BMI, WHtR,
WC, and attained education level in-
creased (all overall P , 0.05) (Table 1).
The crude prevalence of diabetes changed
from 8.4% (95% CI 7.7–9.1%) in 1988–
1994 to 12.1% (11.3–13.1%) in 2005–
2010, with a relative increase of 44.8%
(28.3–61.3%) between the two survey
periods. There was less change of preva-
lence of undiagnosed diabetes (P =
0.053). The change in education levels
reflected the demographics change in
the U.S. (Table 1).
The mean (SE) values among the six
BMI groups (,18.9, 18.9–24.9, 25.0–
29.9, 30.0–34.9, 35.0–39.9, $40) of all
survey participants were 17.6 (0.1), 22.2
(0.1), 27.3 (0.1), 32.2 (0.1), 37.2 (0.1),
and 45.1 (0.4), respectively, for those
20–34 years of age; 17.5 (0.1), 22.6
(0.1), 27.4 (0.1), 32.2 (0.1), 37.2 (0.1),
and 45.3 (0.3) for those 35–64; and 17.4
(0.1), 22.6 (0.1), 27.4 (0.1), 31.9 (0.1),
36.9 (0.1), and 44.0 (0.3) for those $65.
The mean values of anthropometric mea-
surements by the three age-groups (20–
34, 35–64, and $65) were 26.5 (0.1),
28.6 (0.1), and 27.8 (0.1), respectively,
for BMI; 89.8 (0.3), 97.7 (0.2), and 99.3
(0.3) for WC; and 0.529 (0.002), 0.577
(0.001), and 0.603 (0.002) for WHtR.
The estimated number (in millions)
of adults with diabetes grew from 14.9
(95% CI 13.3–16.4) in 1988–1994 to
26.1 (23.8–28.3) in 2005–2010, result-
ing in an increase of 11.2 prevalent cases
(a 75.5% [52.1–98.9%] increase). Youn-
ger adults contributed 5.5% (2.5–8.4%),
middle-aged adults contributed 52.9%
(43.4–62.3%), and older adults contrib-
uted 41.7% (31.9–51.4%) of the in-
creased number of cases. In each survey
time period, the number of adults with
diabetes increased with age until ;60–
69 years; thereafter, it decreased (Fig. 1).
The gap between NHANES 1988–1994
and NHANES 2005–2010 for each age-
group represents the increase in the num-
ber of prevalent diabetes cases; the largest
increase of cases occurred in middle-aged
and older adults.
After adjusting for sex, race/ethnicity,
and education after age 34, the prevalence
of diabetes was higher with each succes-
sive time period, and this increase was
most pronounced among those$65 (Fig.
2). In each time period, prevalence
peaked between 60 and 69 years of age.
Table 2 demonstrates the unadjusted
and adjusted prevalence of diabetes by the
three time periods and three age-groups.
Within each age-group, both unadjusted
and sociodemographically adjusted prev-
alence increased across time periods. By
2005–2010, versus 1988–1994, the prev-
alence difference of diabetes adjusted for
sociodemographic characteristics was






(n = 7,880) P value
Age (year) 44.1 (43.3–45.0) 45.0 (44.2–45.9) 46.5 (45.7–47.3) , 0.001
Age-group (%)
20–34 years 35.0 (32.5–37.6) 29.9 (27.8–32.1) 27.7 (26.0–29.5) , 0.001
35–64 years 48.5 (46.2–50.8) 54.1 (52.3–56.0) 55.0 (53.3–56.7)
$65 years 16.5 (14.9–18.2) 15.9 (14.7–17.2) 17.3 (16.0–18.7)
Sex (%)
Male 47.6 (46.1–49.2) 47.8 (46.8–48.9) 48.2 (46.9–49.4) 0.827
Female 52.4 (50.8–53.9) 52.2 (51.1–53.2) 51.8 (50.6–53.1)
Race/ethnicity (%)
Non-Hispanic white 76.3 (73.0–79.4) 72.3 (68.5–75.8) 69.8 (66.2–73.2) 0.062
Non-Hispanic black 10.9 (9.5–12.6) 11.2 (9.1–13.6) 11.4 (9.7–13.3)
Mexican American 5.1 (4.2–6.1) 7.1 (5.5–9.1) 8.3 (6.7–10.3)
Other 7.6 (5.8–10.1) 9.4 (7.0–12.4) 10.5 (8.7–12.6)
Highest education level (%)
Less than high school 24.4 (22.2–26.8) 20.9 (19.3–22.6) 18.4 (16.8–20.1) , 0.001
High school graduate 33.4 (31.4–35.3) 26.0 (24.1–28.1) 24.2 (22.6–25.9)
More than high school 42.2 (39.5–44.9) 53.1 (50.6–55.6) 57.4 (54.7–60.1)
WC (cm) 91.8 (91.2–92.5) 96.1 (95.4–96.7) 98.2 (97.6–98.8) , 0.001
WHtR 0.55 (0.54–0.55) 0.57 (0.56–0.57) 0.58 (0.58–0.59) , 0.001
BMI (kg/m2) 26.5 (26.3–26.8) 28.0 (27.8–28.3) 28.7 (28.5–28.9) , 0.001
BMI group (%)
,18.9 2.0 (1.5–2.5) 1.9 (1.4–2.4) 1.8 (1.3–2.2) , 0.001
18.9–24.9 43.5 (41.6–45.5) 34.3 (32.6–36.0) 30.7 (29.2–32.2)
25.0–29.9 32.5 (30.9–34.0) 33.9 (31.9–35.9) 33.0 (31.6–34.4)
30.0–34.9 14.0 (12.7–15.3) 17.8 (16.6–19.0) 19.0 (17.8–20.2)
35.0–39.9 5.3 (4.5–6.1) 7.3 (6.4–8.1) 9.2 (8.1–10.2)
$40 2.7 (2.1–3.2) 4.9 (4.1–5.7) 6.4 (5.7–7.0)
Undiagnosed diabetes (%) 3.3 (2.8–3.8) 3.1 (2.6–3.6) 3.9 (3.4–4.4) 0.053
Diabetes (diagnosed + undiagnosed) (%) 8.4 (7.7–9.1) 9.8 (9.1–10.6) 12.1 (11.3–13.1) , 0.001
Data are mean or % (95% CI).
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Changing diabetes prevalence
much higher among older adults (10.0%)
than among younger adults (1.0%) and
middle-aged adults (2.7%) (all P ,
0.001). The adjusted PRs (2005–2010
vs. 1988–1994) were 1.5, 1.3, and 2.3
for older, middle-aged, and younger
adults, respectively; there were no statis-
tically significant differences in the PRs of
diabetes among these three age-groups.
After additional adjustment for BMI,
WHtR, or WC as a continuous variable
in separate models, the PDs and PRs be-
tween the first and last survey period were
attenuated; especially after adjusting for
WHtR or WC, both PD and PR remained
statistically significant only among adults
$65 years of age (Table 2).
CONCLUSIONSdFrom 1988 to
2010, the prevalence of diagnosed and
undiagnosed diabetes increased by 45%,
and the total number of persons with
diabetes increased by almost 75%.
Whereas diabetes prevalence increased
by a similar magnitude across age-groups
in relative terms, by far the greatest
absolute increases in prevalence were
observed in U.S. adults;65 years of age.
From 1988 to 2010, obesity, as measured
by BMI, WHtR, orWC, explained most of
the increase of diabetes prevalence among
adults ,65 years of age but only part of
the increase among those $65.
Adjusting for BMI, WHtR, or WC
attenuated the increase in diabetes prev-
alence, especially among younger and
middle-aged adults, reiterating the prior
observation that obesity is a major de-
terminant of diabetes trends in the pop-
ulation (13). Definitions of obesity
measurement remain controversial (14).
Between BMI and WHtR, two major clin-
ical indicators of obesity, BMI is the most
commonly used (15), but WHtR might
be a better predictor of cardiometabolic
risk factors and diabetes (9,16,17). In
the present study, abdominal obesity as
measured by WHtR or WC accounted
for slightly more variation in change of
diabetes prevalence than did BMI (P ,
0.001).
When adjusted for BMI, WHtR, or
WC, the increase in prevalence of diabetes
among older adults from 1988–1994 to
2005–2010 was smaller in both relative
and absolute terms but still remained sig-
nificantly large. There are several poten-
tial reasons for this difference between
adults $65 years of age and the other
two age-groups. Prevalence is a function
of both incidence and mortality. The U.S.
studies for this time period of investiga-
tion suggested that although incidence
was increasing (18), mortality was de-
creasing (19). Because adults $65 years
of age have higher death rates than youn-
ger people and have been shown to have
significant declines in all-cause mortality
over time, older adults have benefited
most from decreasing death rates. Hence,
these main drivers of prevalence have a dif-
ferential impact by age. The roles of
Figure 1dTotal number of adults$20 years of age with diabetes by survey year: U.S. NHANES,
1988–2010. Each dot of 1988–1994 (4), 1999–2004 (◇), and 2005–2010 (○) represents the
total number of adults with diabetes within a 5-year age-group. Each line for 1988–1994 (dotted),
1999–2004 (dashed), and 2005–2010 (solid) represents the smoothed trend line of the total number
of adults with diabetes derived from a cubic polynomial regression by age-group (AgeGrp) from 1
(20–24 years) to 13 ($80 years) for each time period. For 1988–1994, 23,893.6*AgeGrp3 +
52,915*AgeGrp2 + 53,590*AgeGrp – 85,885; for 1999–2004, 23,254.7*AgeGrp3 +
30,451*AgeGrp2 + 274,991*AgeGrp – 263,749; and for 2005–2010, 25,520.1*AgeGrp3 +
68,979*AgeGrp2 + 204,097*AgeGrp – 253,127.
Figure 2dAge-specific unadjusted and sex-, race/ethnicity-, and education-adjusted preva-
lence of diabetes in adults $20 years of age by survey year: U.S. NHANES, 1988–2010. Each
dot of 1988–1994 (4), 1999–2004 (◇), and 2005–2010 (○) represents the unadjusted
prevalence within a 5-year age-group. Each line for 1988–1994 (dotted), 1999–2004 (dashed),
and 2005–2010 (solid) represents the sex-, race/ethnicity-, and education-adjusted predicted
prevalence of the midpoint of the 5-year age-group from piecewise regression, with age as
a continuous variable.
care.diabetesjournals.org DIABETES CARE, VOLUME 36, SEPTEMBER 2013 2693
Cheng and Associates
incidence and mortality in diabetes on the
increasing prevalence of diabetes may still
be controversial. A Canadian population-
based study demonstrated that from
1995 to 2005, the increasing prevalence
of self-reported diabetes was due to both
increasing incidence and decreasing mor-
tality (20). The Danish National Diabetes
Register reported that from 1995 to 2006,
mortality rates in the diabetic population
decreased 4% per year compared with 2%
per year in the nondiabetic population
(21). An Italian population-based study
showed that from 2000 to 2007, the in-
cidence rate of diabetes did not change,
but mortality decreased yearly by 3.0%
(3). A Finnish study showed that in young
adults who were 15–39 years of age be-
tween 1992 and 2001, the incidence of
both type 1 and type 2 diabetes increased
on average by 3.9 and 4.3%, respectively
(22). In each of these three reports, undi-
agnosed diabetes could not be identified;
hence, the true prevalence and incidence
of total diabetes would have been under-
estimated.
In addition, the unequal change of
exposure level and the effect of mortality
and incident diabetes risk factors by age-
group may also explain this difference in
the secular change of prevalence between
age-groups. Generally, adults gain weight
until about age 60, followed by weight
loss (23), which when unintentional, may
be a significant indicator of frailty among
older adults (24). Therefore, it is plausible
that obesity among older adults may not
be as strong a risk factor as among
younger adults according to the present
study. On the other hand, the presence
and treatment of comorbid conditions
may increase diabetes risk among older
adults. For example, the Women’s Health
Initiative and other studies reported an
increased risk of diabetes among persons
taking statins (25,26). Additionally, med-
ications used to treat arthritis or chronic
obstructive pulmonary disease could in-
crease the patient’s risk of insulin resistance
or diabetes (27,28). However, we need to
cautiously interpret the correlation of the
three anthropometric obesity measures
with diabetes, especially among older frail
adults. As we expected, adults 35–64 years
of age had the highest mean value of BMI,
whereas those $65 had the highest mean
values of WC andWHtR. These surrogates
Table 2dPrevalence of diabetes among adults aged ‡20 years by age-group: U.S. NHANES, 1988–2010†
20–34 years 35–64 years $65 years All‡
Unadjusted
1988–1994 0.83 (0.50–1.15) 9.96 (8.59–11.32) 19.77 (17.72–21.82) 8.79 (7.99–9.59)
1999–2004 1.91 (1.14–2.68) 10.16 (9.12–11.20) 23.67 (21.12–26.21) 9.88 (9.09–10.66)
2005–2010 1.90 (1.45–2.34) 12.25 (10.92–13.59) 28.16 (25.85–30.47) 11.72 (10.87–12.57)
PD (2005–2010 vs. 1988–1994) 1.07 (0.52–1.62)*** 2.29 (0.38–4.21)* 8.39 (5.30–11.48)*** 2.93 (1.76–4.10)***
PR (2005–2010 vs. 1988–1994) 2.29 (1.24–3.34)* 1.23 (1.01–1.45)* 1.42 (1.24–1.61)*** 1.33 (1.18–1.49)***
Adjusted for sex,
race/ethnicity, education
1988–1994 0.81 (0.49–1.14) 9.88 (8.55–11.20) 18.58 (16.58–20.59) 8.49 (7.76–9.23)
1999–2004 1.83 (1.08–2.57) 10.46 (9.44–11.48) 23.70 (21.19–26.22) 9.97 (9.20–10.74)
2005–2010 1.85 (1.41–2.29) 12.62 (11.29–13.95) 28.54 (26.26–30.82) 11.91 (11.08–12.74)
PD (2005–2010 vs. 1988–1994) 1.04 (0.49–1.58)** 2.74 (0.88–4.61)** 9.96 (7.04–12.88)* 3.42 (2.32–4.52)**
PR (2005–2010 vs. 1988–1994) 2.28 (1.21–3.32)* 1.28 (1.06–1.49)* 1.54 (1.34–1.73)* 1.40 (1.25–1.56)***
Adjusted for sex, race/ethnicity,
education, BMI‡
1988–1994 1.13 (0.69–1.58) 10.25 (8.93–11.56) 20.96 (18.88–23.04) 9.44 (8.67–10.21)
1999–2004 1.96 (1.17–2.74) 9.70 (8.86–10.54) 24.16 (21.79–26.52) 9.91 (9.18–10.64)
2005–2010 1.80 (1.39–2.21) 11.00 (9.87–12.12) 27.35 (25.16–29.55) 11.12 (10.36–11.88)
PD (2005–2010 vs. 1988–1994) 0.67 (0.06–1.28)* 0.75 (20.97 to 2.47) 6.39 (3.56–9.23)*** 1.68 (0.62–2.73)**
PR (2005–2010 vs. 1988–1994) 1.59 (0.86–2.32) 1.07 (0.90–1.25) 1.30 (1.15–1.46)*** 1.18 (1.06–1.30)**
Adjusted for sex, race/ethnicity,
education, WC‡
1988–1994 1.39 (0.85–1.93) 10.52 (9.18–11.85) 19.17 (17.21–21.14) 9.83 (9.05–10.60)
1999–2004 2.17 (1.29–3.05) 9.58 (8.74–10.43) 21.30 (19.10–23.50) 9.90 (9.15–10.65)
2005–2010 1.96 (1.51–2.42) 10.52 (9.44–11.61) 23.86 (21.92–25.81) 10.84 (10.08–11.59)
PD (2005–2010 vs. 1988–1994) 0.57 (20.14 to 1.28) 0.00 (21.72 to 1.73) 4.69 (2.15–7.23)*** 1.01 (20.04 to 2.06)
PR (2005–2010 vs. 1988–1994) 1.41 (0.77–2.05) 1.00 (0.84–1.16) 1.24 (1.09–1.39)** 1.10 (0.99–1.22)
Adjusted for sex, race/ethnicity,
education, WHtR‡
1988–1994 1.47 (0.90–2.04) 10.53 (9.21–11.85) 17.73 (15.95–19.52) 9.77 (8.99–10.55)
1999–2004 2.34 (1.41–3.28) 9.73 (8.87–10.59) 19.82 (17.63–21.91) 9.94 (9.20–10.68)
2005–2010 2.05 (1.57–2.52) 10.66 (9.59–11.73) 22.18 (20.31–24.05) 10.84 (10.10–11.58)
PD (2005–2010 vs. 1988–1994) 0.58 (20.17 to 1.33) 0.13 (21.57 to 1.82) 4.45 (2.09–6.81)*** 1.07 (0.03–2.11)*
PR (2005–2010 vs. 1988–1994) 1.39 (0.76–2.03) 1.01 (0.85–1.17) 1.25 (1.10–1.40)** 1.11 (1.00–1.22)
Data are prevalence (%), prevalence difference (PD, %), or prevalence ratio (PR) (95% CI). †1,440 adults without BMI,WC, orWHtR values used 10 sets of MI values.
‡The prevalence for all adults $20 years of age had additional adjustments of three age-groups. *P , 0.05. **P , 0.01. ***P , 0.001.
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cannot represent the actual adiposity level
exactly, which could be a potential source
of residual confounding.
In the present study, the PR of di-
abetes between the first and last time
period of the survey became statistically
nonsignificant after adjusting for BMI,
WHtR, or WC for younger and middle-
aged adults only. Recent analyses of data
from locally and nationally representative
surveys suggested that obesity prevalence
trends measured by BMI reach a plateau
(15,29,30), which raises questions about
whether a similar plateau might be antic-
ipated for the prevalence of diabetes. Fu-
ture research as well as close surveillance
monitoring of incident and prevalent di-
abetes that follow population-level pla-
teaus in obesity prevalence may be
particularly helpful in explaining further
the age-specific differences in increasingly
prevalent diabetes over time.
Misclassification might occur as a re-
sult of recall error or change over time in
diagnostic criteria for diabetes. In 1997,
the American Diabetes Association (ADA)
lowered the FPG level for diagnosing
diabetes from 140 to 126 mg/L and
encouraged the use of FPG as the main
diagnostic test rather than the long-time
standard oral glucose tolerance test (31).
In 2009, the ADA recommended the use
of HbA1c for the diagnosis of diabetes
(32). The increase in the prevalence of di-
agnosed diabetes over the three time pe-
riods may be partly a result of the changes
in the diagnostic criteria and increase in
screening. The frequency of glucose test-
ing might also affect the prevalence of
self-reported diabetes. However, in the
present study, we used both diagnosed
and undiagnosed diabetes, and this ap-
proach may have minimized the impact
of changes of diagnostic criteria and fre-
quency of glucose testing.
This study has a few limitations. First,
we could not distinguish between type 1
and type 2 diabetes. Second, the study
was inherently limited by the nature of
cross-sectional national surveys; there-
fore, we were unable to show a causal
relationship and to evaluate the lifetime
effect of obesity exposure. Finally, al-
though self-reported diabetes is a valid
measure of diabetes presence (33–35), we
relied on a one-time measurement of FPG
level or HbA1c to define undiagnosed di-
abetes, whereas retesting is suggested for
diabetes diagnosis in clinical settings.
This could have caused some degree of
discrepancy with clinical settings, but
there are no reasons to believe that the
misclassification rate of diabetes between
clinical settings and surveys would
change over time. We speculate that the
incremental change in the prevalence of
diabetes in the U.S. population relates to
the decrease in fatality among diabetic in-
dividuals, the aging of the population,
and the increase in incident diabetes (36).
During the past two decades, the
prevalence of diabetes increased across
all ages, with the most prominent change
among adults $65, which accounts for
42% of the growth in number of prevalent
cases. Obesity, as measured by BMI and
WHtR, is strongly associated with the in-
crease in diabetes prevalence, especially
in younger and middle-aged adults, and
is generally congruent with the existing
obesity epidemic as a driving force for
the increase in diabetes prevalence for all
age-groups and reinforces the call for
prevention efforts. The increased preva-
lence among older adults, likely the result
of an aging population and successes in
diabetes control (37), underscores the ur-
gent need for planning and delivering
quality health care for this growing seg-
ment of the population (38).
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